Mona P. Rosenberg

Medicine · Health Sciences

15h-index1.3kcitations25works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Veterinary Oncology Research(20), Infectious Diseases and Mycology(9), Mast cells and histamine(6), Salivary Gland Tumors Diagnosis and Treatment(3), Microbial infections and disease research(3)

Publications25 total

CCR Translation for the Article from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Supplementary Data from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Data from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Supplementary Data from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
CCR Translation for the Article from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Data from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
2023Open Access
Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma
Journal of Veterinary Internal Medicine·2021· 17 citedOpen Access
Letter to Editor
Journal of Veterinary Internal Medicine·2015Open Access
A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs
Journal of Veterinary Internal Medicine·2015· 127 citedOpen Access
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma
BMC Veterinary Research·2015· 47 citedOpen Access
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study
PLoS ONE·2015· 77 citedOpen Access
Prospective Evaluation of Biweekly Streptozotocin in 19 Dogs with Insulinoma
Journal of Veterinary Internal Medicine·2013· 31 cited
PROSPECTIVE EVALUATION OF A 5 × 4 Gy PRESCRIPTION FOR PALLIATION OF CANINE NASAL TUMORS
Veterinary Radiology & Ultrasound·2012· 27 cited
Evaluation of lomustine as a rescue agent for cats with resistant lymphoma
Journal of Feline Medicine and Surgery·2012· 29 citedOpen Access
A Randomized Trial Investigating the Efficacy and Safety of Water Soluble Micellar Paclitaxel (Paccal Vet) for Treatment of Nonresectable Grade 2 or 3 Mast Cell Tumors in Dogs
Journal of Veterinary Internal Medicine·2012· 40 citedOpen Access
An Open-Label, Dose-Escalating Phase I Study of Elsamitrucin (SPI 28090) in Treatment of Malignant Solid Tumors in Dogs
Journal of Veterinary Internal Medicine·2011· 5 citedOpen Access
Evaluation of adverse events in cats receiving long-term piroxicam therapy for various neoplasms
Journal of Feline Medicine and Surgery·2010· 24 citedOpen Access
Rash associated with pandemic (H1N1) influenza
Canadian Medical Association Journal·2009· 12 citedOpen Access
Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
Clinical Cancer Research·2009· 416 citedOpen Access
Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas
American Journal of Veterinary Research·2006· 35 cited
page 1 of 2Next →

Frequent Co-authors

Cheryl A. London(11), Carolyn J. Henry(10), Mary K. Klein(9), Philip J. Bergman(9), Joseph F. Boucher(8), Phyllis B. Malpas(7), Stacey L. Wood-Follis(7), Anthony Rusk(7), Kathy L. Mitchener(7), John G. Hintermeister(7), Guillermo Couto(7), G. Neal Mauldin(7), Gina Μ. Michels(7), David M. Vail(5), Gerald Post(4), Craig A. Clifford(4), Douglas H. Thamm(4), Nicole C. Northrup(3), Brenda Phillips(3), C. Khanna(2)